The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(4-{4-[4-(1H-benzimidazol-2-yl)-phenylamino]-2-morpholin-4-yl-[1,3,5]triazin-6-yl}-piperazin-1-yl)-ethanol ID: ALA3810285
PubChem CID: 127044240
Max Phase: Preclinical
Molecular Formula: C26H31N9O2
Molecular Weight: 501.60
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: OCCN1CCN(c2nc(Nc3ccc(-c4nc5ccccc5[nH]4)cc3)nc(N3CCOCC3)n2)CC1
Standard InChI: InChI=1S/C26H31N9O2/c36-16-13-33-9-11-34(12-10-33)25-30-24(31-26(32-25)35-14-17-37-18-15-35)27-20-7-5-19(6-8-20)23-28-21-3-1-2-4-22(21)29-23/h1-8,36H,9-18H2,(H,28,29)(H,27,30,31,32)
Standard InChI Key: HFLJLKJLVQYVIZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
37 42 0 0 0 0 0 0 0 0999 V2000
8.5716 0.4033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.7060 1.8887 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.2114 1.7609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3536 2.9915 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.9903 4.3496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4848 4.4773 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.3427 3.2468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1320 5.5807 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.6372 5.4555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7813 6.6873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4201 8.0445 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.9149 8.1698 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7708 6.9380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8380 3.3746 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.0761 0.2776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4347 -1.0784 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9397 -1.2009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0896 0.0290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7275 1.3885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2225 1.5111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 -1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4770 4.7318 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9717 4.8571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8276 3.6252 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.1888 2.2681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6940 2.1428 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3235 3.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1781 2.5138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3741 2.6116 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
2 7 2 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
8 13 1 0
5 8 1 0
7 14 1 0
1 3 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
15 20 2 0
21 22 2 0
22 23 1 0
23 24 1 0
24 25 1 0
21 25 1 0
26 27 1 0
27 28 2 0
28 29 1 0
24 29 2 0
23 26 2 0
18 21 1 0
1 15 1 0
14 30 1 0
30 31 1 0
31 32 1 0
32 33 1 0
33 34 1 0
34 14 1 0
32 35 1 0
35 36 1 0
36 37 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 501.60Molecular Weight (Monoisotopic): 501.2601AlogP: 2.11#Rotatable Bonds: 7Polar Surface Area: 118.56Molecular Species: NEUTRALHBA: 10HBD: 3#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 3#RO5 Violations (Lipinski): 2CX Acidic pKa: 11.56CX Basic pKa: 7.12CX LogP: 3.80CX LogD: 3.60Aromatic Rings: 4Heavy Atoms: 37QED Weighted: 0.35Np Likeness Score: -1.51
References 1. Singla P, Luxami V, Paul K.. (2016) Synthesis and in vitro evaluation of novel triazine analogues as anticancer agents and their interaction studies with bovine serum albumin., 117 [PMID:27089212 ] [10.1016/j.ejmech.2016.03.088 ]